It is great to see the results of this testing conducted by Loughborough University in print.
Seracam’s performance characterisation results have been published for the first time by our academic partners at Loughborough University: “The results of this work clearly demonstrate that for SFOV [small field of view] imaging, Seracam offers the potential to extend the utility of nuclear medicine investigations beyond the restraints of the larger fixed camera systems.” Congratulations to Sarah Bugby and the team on this important publication. The open access article is available here: https://lnkd.in/eNPgeUC7 Seracam® is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities. #medicalimaging #diagnosticimaging #gammaimaging #hybridimaging #nuclearmedicine #molecularimaging
